Cargando…
Current therapies and new developments in NASH
Non-alcoholic steatohepatitis is becoming the most important aetiology for advanced liver disease. There has been important progress in the field in recent years and the complexity of the pathophysiology of NASH is better understood. Multiple non-invasive circulating and imaging biomarkers have been...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484366/ https://www.ncbi.nlm.nih.gov/pubmed/35710299 http://dx.doi.org/10.1136/gutjnl-2021-326874 |
_version_ | 1784791867203780608 |
---|---|
author | Dufour, Jean-François Anstee, Quentin M Bugianesi, Elisabetta Harrison, Stephen Loomba, Rohit Paradis, Valerie Tilg, Herbert Wong, Vincent Wai-Sun Zelber-sagi, Shira |
author_facet | Dufour, Jean-François Anstee, Quentin M Bugianesi, Elisabetta Harrison, Stephen Loomba, Rohit Paradis, Valerie Tilg, Herbert Wong, Vincent Wai-Sun Zelber-sagi, Shira |
author_sort | Dufour, Jean-François |
collection | PubMed |
description | Non-alcoholic steatohepatitis is becoming the most important aetiology for advanced liver disease. There has been important progress in the field in recent years and the complexity of the pathophysiology of NASH is better understood. Multiple non-invasive circulating and imaging biomarkers have been tested. The importance of lifestyle has been recognised and several drugs are being tested in clinical trials. This review addresses the challenges that healthcare professionals face in the management of NASH patients. |
format | Online Article Text |
id | pubmed-9484366 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-94843662022-09-20 Current therapies and new developments in NASH Dufour, Jean-François Anstee, Quentin M Bugianesi, Elisabetta Harrison, Stephen Loomba, Rohit Paradis, Valerie Tilg, Herbert Wong, Vincent Wai-Sun Zelber-sagi, Shira Gut Recent Advances in Clinical Practice Non-alcoholic steatohepatitis is becoming the most important aetiology for advanced liver disease. There has been important progress in the field in recent years and the complexity of the pathophysiology of NASH is better understood. Multiple non-invasive circulating and imaging biomarkers have been tested. The importance of lifestyle has been recognised and several drugs are being tested in clinical trials. This review addresses the challenges that healthcare professionals face in the management of NASH patients. BMJ Publishing Group 2022-10 2022-06-16 /pmc/articles/PMC9484366/ /pubmed/35710299 http://dx.doi.org/10.1136/gutjnl-2021-326874 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Recent Advances in Clinical Practice Dufour, Jean-François Anstee, Quentin M Bugianesi, Elisabetta Harrison, Stephen Loomba, Rohit Paradis, Valerie Tilg, Herbert Wong, Vincent Wai-Sun Zelber-sagi, Shira Current therapies and new developments in NASH |
title | Current therapies and new developments in NASH |
title_full | Current therapies and new developments in NASH |
title_fullStr | Current therapies and new developments in NASH |
title_full_unstemmed | Current therapies and new developments in NASH |
title_short | Current therapies and new developments in NASH |
title_sort | current therapies and new developments in nash |
topic | Recent Advances in Clinical Practice |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484366/ https://www.ncbi.nlm.nih.gov/pubmed/35710299 http://dx.doi.org/10.1136/gutjnl-2021-326874 |
work_keys_str_mv | AT dufourjeanfrancois currenttherapiesandnewdevelopmentsinnash AT ansteequentinm currenttherapiesandnewdevelopmentsinnash AT bugianesielisabetta currenttherapiesandnewdevelopmentsinnash AT harrisonstephen currenttherapiesandnewdevelopmentsinnash AT loombarohit currenttherapiesandnewdevelopmentsinnash AT paradisvalerie currenttherapiesandnewdevelopmentsinnash AT tilgherbert currenttherapiesandnewdevelopmentsinnash AT wongvincentwaisun currenttherapiesandnewdevelopmentsinnash AT zelbersagishira currenttherapiesandnewdevelopmentsinnash |